Trial
NCT04996667
Effect of iNO in Patients With Submassive and Massive PE
Phase IIWITHDRAWNOTHER/UNKNOWNConfidence: LOW
Sponsor
University of California, Los Angeles
Collaborators
Mallinckrodt
Condition
Pulmonary Embolism
Intervention
inhaled nitric oxide (iNO)
Why stopped
no sponsor support
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2026-03-18